Experience of Femoston Treatment in Perimenopausal Women Receiving Oral Corticosteroid Therapy
A. V. Dreval , L. A. Marchenkova , E. Y. Polyakova , I. V. Kryukova , R. S. Tishenina , N. D. Gasparyan , D. V. Grigorieva , A. V. Koroleva
Journal of obstetrics and women's diseases ›› 2003, Vol. 52 ›› Issue (4) : 55 -59.
Experience of Femoston Treatment in Perimenopausal Women Receiving Oral Corticosteroid Therapy
Chronic oral corticosteroid therapy, which is widely used for the treatment of bronchial asthma, dermatological, rheumatic diseases, systemic diseases of the connective tissue, etc., is often a psychological obstacle to the appointment of hormone replacement therapy (HRT) for women in menopause. At the same time, the appointment of estrogenic drugs for this category of patients in some cases is necessary, since by reducing climacteric symptoms, stopping urogenital disorders and increasing the level of bone mass, HRT can significantly improve the quality of life.
femoston treatment / perimenopausal woman / oral corticosteroid therapy / estrogenic drug / femoston
Eсо-Vector
/
| 〈 |
|
〉 |
PDF
